Skip to main content

Weight Loss Drug Ozempic Helps with Depression and Anxiety

Published on June 23, 2026, 5:54 p.m.
Weight Loss Drug Ozempic Helps with Depression and Anxiety

Topic: Health

A study found that people taking a weight loss drug called Ozempic had fewer hospital visits for mental health issues and took less time off work. The drug, used to treat diabetes and obesity, was also linked to reduced depression and anxiety.

This large-scale study looked at data from nearly 100,000 individuals in Sweden. Researchers found that people using a type of medication called GLP-1 receptor agonists had fewer psychiatric hospital visits and took less time off work due to mental health issues. The strongest link was with a drug called semaglutide, which is used to treat diabetes and obesity.

The study also showed that people taking this medication had a 44% lower risk of depression and a 38% lower risk of anxiety disorders. Additionally, the need for hospital care and time off work related to substance use was 47% lower during treatment periods.

The researchers think that these medications might be helping mental health by reducing alcohol consumption, improving body image, or providing relief from better blood sugar control in diabetes. However, they also found a strong association between the medication and improved mental health, which suggests there may be direct effects on the brain.

Why It Matters

This study is important because it shows that a common treatment for diabetes and obesity might also help with depression and anxiety. This could lead to new ways of treating these conditions, especially in areas where access to mental health services is limited.

Key Facts

  • The study looked at data from nearly 100,000 individuals in Sweden over a 13-year period.
  • People taking semaglutide had a 44% lower risk of depression and a 38% lower risk of anxiety disorders.
  • The need for hospital care and time off work related to substance use was 47% lower during treatment periods.
  • Semaglutide is used to treat diabetes and obesity, but this study found it might also help with mental health issues.
  • The study suggests that the medication could be helping mental health by reducing alcohol consumption or providing relief from better blood sugar control.

Key Terms

GLP-1 receptor agonists
A type of medication used to treat diabetes and obesity

Implications

This study is important because it shows that a common treatment for diabetes and obesity might also help with depression and anxiety. This could lead to new ways of treating these conditions, especially in areas where access to mental health services is limited.


Source: https://www.sciencedaily.com/releases/2026/03/260322020250.htm

Journal Reference:

  1. Heidi Taipale, Mark Taylor, Markku Lähteenvuo, Ellenor Mittendorfer-Rutz, Antti Tanskanen, Jari Tiihonen. Association between GLP-1 receptor agonist use and worsening mental illness in people with depression and anxiety in Sweden: a national cohort study. The Lancet Psychiatry, 2026; 13 (4): 327 DOI: 10.1016/S2215-0366(26)00014-3

Leave a Comment

Name
Email
Body
... ...

Get Exclusive Insights

with Every Issue

JoinShalyamNewsletter

Stay ahead in education, research, and innovation—straight to your inbox.